Vésale Bioscience

Stem from our advanced R&D on bacteriophages, our Mission is to develop robust modern solutions to fight antibiotic-resistant infections.

Antibiotic-resistant infections, also known as antimicrobial resistance (AMR), are a substantial public health issue. From 700 000/y deaths today, the AMR burden is expected to reach ten million/y deaths by 2050, more than cancer.

Our approach is to work on personalized, selective, and specific phage therapies against those multi-resistant bacterial infections.